Radiotherapy for breast cancer, the TARGIT - A trial (I)

The Lancet

Volumn 383, Issue 9930, 2014, Pages 1717-1718

  Yarnold, John ^a   Offersen, Birgitte Vrou ^b   Olivotto, Ivo ^c   Poortmans, Philip ^d   Sarin, Rajiv ^e  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c TOM BAKER CANCER CENTRE   (Canada)

^d DR BERNARD VERBEETEN INSTITUTE   (Netherlands)

^e TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER RADIOTHERAPY; CAUSE OF DEATH; HEART DEATH; HUMAN; INTRAOPERATIVE RADIOTHERAPY; LETTER; LUNG CANCER; MASTECTOMY; PRIMARY TUMOR; PRIORITY JOURNAL; BREAST TUMOR; FEMALE; NOTE; PAGET NIPPLE DISEASE; EXTERNAL BEAM RADIOTHERAPY; MORBIDITY; RADIATION HAZARD; RISK ASSESSMENT;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS;

EID: 84900545409     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)60828-X     Document Type: Letter

References (4)

1. Vaidya JS, Wenz F, Bulsara M., et al, on behalf of the TARGIT trialists' group. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet 2014; 383: 603-13.
2. Baum M. A revolution in breast cancer therapy. London: The Telegraph, Nov 10, 2013.
3. Darby SC, Ewertz M, McGale P., et al Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013; 368: 987-98.
4. Deutsch M, Land SR, Begovic M, Wieand H.S., Wolmark N., Fisher B. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of national surgical adjuvant breast and bowel project (NSABP) clinical trials B-04 and B-06. Cancer 2003. 98: 1362-68.